Bevacizumab Versus Docetaxel/Erlotinib on Tumor Metrics in Patients With Previously Untreated Advanced Non Small Cell Lung Cancer
NCT04257864 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 58
Last updated 2020-02-10
Summary
To determine the more effective dosing sequence of intermittent erlotinib and docetaxel for treating patients with the diagnosis of advanced Non-Small-Lung-Cancer.
Conditions
- Non Small Cell Lung Cancer
Sponsors & Collaborators
-
Hellenic Cooperative Oncology Group
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-11-30
- Primary Completion
- 2010-05-31
- Completion
- 2014-06-30
More Related Trials
-
Combination of Erlotinib and Bevacizumab as Second-line Treatment in Patients With Non-small Cell Lung Cancer
NCT00749567 ·Status: TERMINATED ·Phase: PHASE2
-
Carboplatin, Docetaxel, Bevacizumab, and Erlotinib Versus Chemotherapy Alone in Resected NSCLC
NCT00621049 ·Status: COMPLETED ·Phase: PHASE2
-
Paclitaxel-bevacizumab in Advanced Lung Cancer
NCT01763671 ·Status: COMPLETED ·Phase: PHASE3
-
Metronomic Docetaxel and Bevacizumab in Patients With Small Cell Lung Cancer
NCT00755157 ·Status: WITHDRAWN ·Phase: PHASE2
-
Docetaxel and Carboplatin Versus Docetaxel as Second Line Treatment in Patients With Non-Small-Cell Lung Carcinoma (NSCLC)
NCT00430651 ·Status: COMPLETED ·Phase: PHASE3
-
Bevacizumab, Docetaxel, and Gemcitabine Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer
NCT00970684 ·Status: COMPLETED ·Phase: PHASE2
-
Bevacizumab and Docetaxel in Treating Older Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
NCT00541099 ·Status: COMPLETED ·Phase: PHASE2
-
Carboplatin, Abraxane, and Bevacizumab in Previously Untreated Patients With Advanced Non-Small Cell Lung Cancer
NCT00642759 ·Status: COMPLETED ·Phase: PHASE2
-
Paclitaxel in Combination With Bevacizumab in Patients With Stage IV NSCLC.
NCT04640935 ·Status: COMPLETED
-
Cisplatin/Vinorelbine/Bevacizumab Followed by Docetaxel/Gemcitabine/Bevacizumab Versus the Cisplatin/Docetaxel/Bevacizumab Combination in Locally Advanced or Metastatic NSCLC
NCT00620971 ·Status: COMPLETED ·Phase: PHASE2
-
Carboplatin, Paclitaxel, and Bevacizumab With or Without Erlotinib Hydrochloride in Treating Non-Smokers With Advanced Non-Small Cell Lung Cancer
NCT00976677 ·Status: TERMINATED ·Phase: PHASE2
-
Observational Post-authorization Studies Carboplatin, Paclitaxel and Bevacizumab
NCT01814163 ·Status: COMPLETED
-
Biweekly Gemcitabine and Docetaxel as First Line Therapy for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients
NCT00906061 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study of Bevacizumab Versus Placebo in Combination With Carboplatin/Paclitaxel in Participants With Advanced or Recurrent Non-Squamous Non-Small Cell Lung Cancer Who Have Not Received Previous Chemotherapy
NCT01364012 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate Bevacizumab and Chemotherapy or Tarceva in Treating Recurrent or Refractory NSCLC (Non-Small Cell Lung Cancer)
NCT00095225 ·Status: COMPLETED ·Phase: PHASE2
-
Bevacizumab and Erlotinib Followed by Cisplatin or Carboplatin and Gemcitabine in Treating Patients With Newly Diagnosed or Recurrent Stage IIIB or Stage IV NSCLC
NCT00354549 ·Status: COMPLETED ·Phase: PHASE2
-
S0819: Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer
NCT00946712 ·Status: TERMINATED ·Phase: PHASE3
-
Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Advanced, Metastatic, or Recurrent Non-Small Cell Lung Cancer
NCT00021060 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Bevacizumab, Cisplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
NCT00387699 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Tarceva (Erlotinib) in Combination With Avastin (Bevacizumab) in Patients With Advanced Non-Small Cell Lung Cancer.
NCT00531960 ·Status: COMPLETED ·Phase: PHASE2
-
An Observational Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic or Recurrent Non-Squamous Non-Small Cell Lung Cancer
NCT01333007 ·Status: COMPLETED
-
An Observational Study of Avastin (Bevacizumab) in Elderly Patients With Non-Squamous Non-Small Cell Lung Cancer in Clinical Practice
NCT01893268 ·Status: COMPLETED
-
Effectiveness and Safety of Adding Bevacizumab to First Line Chemotherapy in Lung Cancer Patients With Stable Disease
NCT03240549 ·Status: UNKNOWN ·Phase: PHASE2
-
Docetaxel in Treating Patients With Non-Small Cell Lung Cancer
NCT00022022 ·Status: UNKNOWN ·Phase: PHASE3
-
Bevacizumab and Carboplatin/Paclitaxel and Radiation in Non-Small Cell Lung Cancer
NCT00578149 ·Status: COMPLETED ·Phase: PHASE2